Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma

Objective: Emerging evidence highlights the implications of the toll-like receptor (TLR) signaling pathway in the pathogenesis and therapeutic regimens of hepatocellular carcinoma (HCC). Herein, a prognostic TLR-based gene signature was conducted for HCC. Methods: HCC-specific TLRs were screened in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lixia, Liu, Bin, Yu, Jie, Zhang, Dongyun, Shi, Jianhong, Liang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490642/
https://www.ncbi.nlm.nih.gov/pubmed/34621787
http://dx.doi.org/10.3389/fmolb.2021.729789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490642/
https://www.ncbi.nlm.nih.gov/pubmed/34621787
http://dx.doi.org/10.3389/fmolb.2021.729789

Ejemplares similares